Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects.
Hae Won LeeWoo Youl KangJi Seo ParkJae Hwa LeeMi-Ri GwonDong Heon YangEun Hee KimSoo-Jin ParkYoung-Ran YoonSook Jin SeongPublished in: Translational and clinical pharmacology (2023)
Clinical Research Information Service Identifier: KCT0004026.
Keyphrases